Should You Avoid Nike Stock, Even at a 12-Year Low?

Nike shares have fallen about 78% from their November 2021 peak near $180 to $38.50, including a roughly 40% year-to-date decline, reaching their lowest level since 2014. Despite the selloff lowering its P/E multiple from 30x in June to about 18x, the article argues the valuation remains unattractive given flat prior-year revenue, a 3% earnings decline, and management's expectation that revenue will fall slightly over the next six months. Cost controls may stabilize earnings and improve margins, but weak demand, inflation, tariffs, and wholesale-market competition keep the turnaround outlook subdued.

Analysis

The key equity risk is not demand alone but the earnings-quality trade-off embedded in Nike’s channel reset. Rebuilding wholesale distribution can improve unit velocity and inventory absorption, but it typically requires lower realized pricing, retailer allowances and less favorable mix versus direct-to-consumer; cost controls are unlikely to fully offset that gross-margin pressure. That leaves consensus vulnerable to another leg of EPS revisions over the next 1-3 quarters even if reported revenue stabilizes.

Competitive leakage is becoming more structural: ONON, DECK and LULU have captured premium footwear/apparel demand while Adidas has regained shelf space and cultural relevance. Nike’s brand scale remains an asset, but a recovery requires product-led sell-through rather than promotional volume; otherwise restored wholesale doors merely shift inventory risk from Nike’s own channels to retail partners. Watch North American wholesale orders, digital full-price sell-through, inventory turns and gross margin—not headline revenue—as the relevant proof points.

At roughly 18x earnings, the stock is no longer priced for the prior peak narrative, but it is not clearly discounted for a prolonged margin reset or a lower terminal growth rate. The contrarian bull case is that pessimism has become sufficiently entrenched that a clean inventory reduction plus evidence of renewed footwear franchise traction could drive a multiple rebound before earnings materially recover. That is a 6-18 month possibility, but the nearer-term setup remains asymmetric to disappointment until management demonstrates that wholesale re-entry is accretive rather than promotional.

Tariff/inflation sensitivity adds a second-order risk: price increases intended to protect margins can widen the value gap versus Adidas and lower-priced private-label alternatives, while absorbing tariffs would delay margin repair. A sustained improvement in full-price mix and gross-margin guidance would falsify the bearish thesis; conversely, any reduction in annual EPS guidance or evidence of elevated retailer inventories should pressure the shares further.

Key Decisions for Investors

• Maintain an underweight/short bias in NKE into the next two earnings updates; use rallies toward a 20-22x forward EPS valuation range to initiate rather than chase weakness. Target a 15-20% downside if consensus EPS is revised lower; cover if management raises gross-margin outlook while wholesale orders and inventory turns improve simultaneously.
• Express the competitive-share thesis as long ONON or DECK versus short NKE on a 3-6 month horizon. The pair reduces broad discretionary risk and isolates the premium-performance/brand-execution gap; exit if Nike reports accelerating full-price footwear sell-through and positive North American wholesale order growth.
• For defined risk, buy NKE 3-6 month put spreads around the next earnings date rather than outright puts, with strikes centered 10-20% below spot. The thesis requires a guidance or margin disappointment, while the spread limits premium decay if the stock remains range-bound after a heavily negative sentiment backdrop.
• Do not treat NFLX, NVDA or GETY as read-through trades from this item; their inclusion is non-fundamental and offers no actionable linkage to Nike’s consumer, channel or margin cycle.